Olpasiran Expanded Access Program

Sponsor
Amgen
Study ID
NCT07079267
Status
Available

Eligibility Criteria

Sex
All
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

Expanded access requests for Olpasiran may be considered for adult participants with elevated Lp(a) and atherosclerotic cardiovascular disease (ASCVD). To request access, use Responsible Party contact information provided in this record.

Key Dates

Status verified
Jul 2025

Central Contacts